Genpact Limited (G): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?

Page 1 of 2

To many of your fellow readers, hedge funds are seen as useless, outdated financial tools of a forgotten age. Although there are more than 8,000 hedge funds in operation currently, Insider Monkey aim at the leaders of this club, about 525 funds. It is widely held that this group controls the lion’s share of all hedge funds’ total assets, and by monitoring their best investments, we’ve spotted a number of investment strategies that have historically outperformed Mr. Market. Our small-cap hedge fund strategy outstripped the S&P 500 index by 18 percentage points per year for a decade in our back tests, and since we’ve started sharing our picks with our subscribers at the end of August 2012, we have outperformed the S&P 500 index by 33 percentage points in 11 months (see all of our picks from August).

Genpact Limited (NYSE:G)

Just as necessary, optimistic insider trading sentiment is another way to analyze the stock market universe. Just as you’d expect, there are plenty of reasons for an insider to drop shares of his or her company, but just one, very clear reason why they would buy. Plenty of academic studies have demonstrated the valuable potential of this strategy if you know where to look (learn more here).

Keeping this in mind, it’s important to analyze the latest info for Genpact Limited (NYSE:G).

How have hedgies been trading Genpact Limited (NYSE:G)?

At the end of the second quarter, a total of 19 of the hedge funds we track were long in this stock, a change of 12% from one quarter earlier. With the smart money’s sentiment swirling, there exists an “upper tier” of key hedge fund managers who were increasing their holdings substantially.

When using filings from the hedgies we track, Eminence Capital, managed by Ricky Sandler, holds the most valuable position in Genpact Limited (NYSE:G). Eminence Capital has a $175.9 million position in the stock, comprising 4.3% of its 13F portfolio. The second largest stake is held by Emerging Sovereign Group, managed by J Kevin Kenny Jr, which held a $58 million position; 2.4% of its 13F portfolio is allocated to the stock. Remaining hedgies that hold long positions include Chuck Royce’s Royce & Associates, David Stemerman’s Conatus Capital Management and Alok Agrawal’s Bloom Tree Partners.

Consequently, particular hedge funds were leading the bulls’ herd. Eminence Capital, managed by Ricky Sandler, established the most outsized position in Genpact Limited (NYSE:G). Eminence Capital had 175.9 million invested in the company at the end of the quarter. J Kevin Kenny Jr’s Emerging Sovereign Group also made a $58 million investment in the stock during the quarter. The other funds with new positions in the stock are Chuck Royce’s Royce & Associates, David Stemerman’s Conatus Capital Management, and Alok Agrawal’s Bloom Tree Partners.

How are insiders trading Genpact Limited (NYSE:G)?

Insider buying made by high-level executives is particularly usable when the company in focus has experienced transactions within the past half-year. Over the latest six-month time frame, Genpact Limited (NYSE:G) has experienced zero unique insiders purchasing, and zero insider sales (see the details of insider trades here).

We’ll also examine the relationship between both of these indicators in other stocks similar to Genpact Limited (NYSE:G). These stocks are FTI Consulting, Inc. (NYSE:FCN), Booz Allen Hamilton Holding Corporation (NYSE:BAH), The Corporate Executive Board Company (NYSE:CEB), Towers Watson & Co (NYSE:TW), and Corrections Corp Of America (NYSE:CXW). This group of stocks are the members of the management services industry and their market caps are closest to G’s market cap.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Click here to Read Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 74 percentage points in 2.5 years. Our beta is only 1.2 (download a FREE newsletter and see the details inside)

Lists

Best Selling Magazines in the World

Shortest People in History

The Most Celebrated Holidays in the World

Most Expensive Handbag Brands in the World

Top Selling Comic Book Issues of this Century

The Most Powerful Women in Politics

Best Paid DJs

Most Rebellious Female Artists

Best Paid TV Actresses of 2014

Best Paid Actors of 2014

Most Expensive Horses in the World

Tallest People Ever

Most Encouraging Feminist Celebrities

Best Paid Supermodels of 2014

Top 10 Suburbs for Retirement in 2015

10 Wealthiest Cities in America

Top 10 TED Talks for Entrepreneurs

Best TED Talks on Education

25 Most Dangerous Places to Live in America

Top 10 Ski Resorts in the United States – 2014 List

Top 10 Most Remote Places in the World

Most Visited Museums in the United States

Wealthiest Photographers in the World

Most Famous Gay Athletes

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!